calcimedica inc glp-1 receptor agonist weight management diabetes treatments Clinical of Regain and Cardiometabolic Consequences After Discontinuation of GLP‐1 Agonists - Shah - 2026 - Diabetes, Obesity and Metabolism Breakthrough of the Year: GLP-1

The Physiological Role of Glucagon-Like Peptide-1 in the Regulation of Renal Function

If validated in adequately powered human trials, this would be a genuinely new mechanism for substance use disorders, rooted in metabolic signalling rather than monoamine modulation

Chiang, C

Pharmacology and Therapeutic Implications of Current Drugs for Type 2 Diabetes Mellitus

However, with significant weight loss comes an increased need for nutritional guidance to help patients maintain quality of life and avoid nutritional deficiencies commonly observed during caloric restriction

[DOI] [PubMed] [Google Scholar] 49.Mehdi SF et al